Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Medinotec (MDNC) Equity Average (2022 - 2025)

Medinotec's Equity Average history spans 4 years, with the latest figure at $5.2 million for Q4 2025.

  • For Q4 2025, Equity Average rose 93.03% year-over-year to $5.2 million; the TTM value through Nov 2025 reached $5.2 million, up 93.03%, while the annual FY2025 figure was $3.2 million, 36.31% up from the prior year.
  • Equity Average reached $5.2 million in Q4 2025 per MDNC's latest filing, up from $4.6 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $5.2 million in Q4 2025 to a low of $1.2 million in Q2 2022.
  • Average Equity Average over 4 years is $2.7 million, with a median of $2.6 million recorded in 2023.
  • Peak YoY movement for Equity Average: surged 124.82% in 2023, then fell 14.71% in 2024.
  • A 4-year view of Equity Average shows it stood at $1.3 million in 2022, then skyrocketed by 73.5% to $2.3 million in 2023, then grew by 15.36% to $2.7 million in 2024, then surged by 93.03% to $5.2 million in 2025.
  • Per Business Quant, the three most recent readings for MDNC's Equity Average are $5.2 million (Q4 2025), $4.6 million (Q3 2025), and $4.3 million (Q2 2025).